Table of conTenTs Welcome address II about GasTRo 2009, UeGW ...

More documents

Recommendations

Info

PosTGRaDUaTe TeacHInG PRoGRaMMe saTURDaY, noVeMbeR 21, 2009 continued 12:00 – 13:00 PARALLEL SESSION 2/ PART 2 Hall N7/8 Fibrogenic diseases of the liver and the pancreas The science and the management: Staging the disease Directors: Massimo Pinzani, Italy; Tania Roskams, Belgium; Markus Lerch, Germany Chair: Scott L. Friedman, USA 12:00 – 12:20 Fibrotic features of chronic hepatic and pancreatic disorders Tania Roskams, Belgium 12:20 – 12:40 Non-invasive methods for the assessment of fibrosis in chronic liver disease Laurent Castera, France 12:40 – 13:00 Non-invasive methods for the assessment of fibrosis in chronic pancreatic disease Julia Mayerle, Germany 14:00 – 15:00 PARALLEL SESSION 2/ PART 3 Hall N7/8 Fibrogenic diseases of the liver and the pancreas The science and the management: Fibrogenesis, angiogenesis and cancer Directors: Massimo Pinzani, Italy; Tania Roskams, Belgium; Markus Lerch, Germany Chair: Tania Roskams, Belgium 14:00 – 14:20 Hepatocellular carcinoma and cholangiocarcinoma Lewis Roberts, USA 14:20 – 14:40 Pancreatic cancer Matthias Loehr, Sweden 14:40 – 15:00 Is there basis for anti-stroma cancer therapy? Massimo Pinzani, Italy 15:00 – 16:00 PARALLEL SESSION 2/ PART 4 Hall N7/8 Fibrogenic diseases of the liver and the pancreas The science and the management: Imaging and Treatment of fibrotic liver and pancreatic disease Directors: Massimo Pinzani, Italy; Tania Roskams, Belgium; Markus Lerch, Germany Chair: Markus Lerch, Germany 15:00 – 15:20 CT and MRI for detecting malignancies Ashley Guthrie, UK 15:20 – 15:40 Interventional endoscopy Marc Giovannini, France 15:40 – 16:00 How to avoid surgery in benign disorders mimicking pancreatic and biliary malignancies Henk Van Buuren, The Netherlands 8
11:00 – 14:00 PARALLEL SESSION 3 / PART 1 Hall N9/10 GORD: Challenges and opportunities PosTGRaDUaTe TeacHInG PRoGRaMMe Director: Jean Paul Galmiche, France Chairs: John Dent, Australia; Jean Paul Galmiche, France 11:00 – 11:30 Epidemiology of GORD and Barrett’s cancer Hashem B. El-Serag, USA 11:30 – 12:00 Pathophysiology of GORD: A new understanding John Dent, Australia 12:00 – 12:30 Oesophageal sensitivity: A new player Qasim Aziz, UK 12:30 – 13:00 PH catheter, bravo capsule, and impedance monitoring: When and how? Frank Zerbib, France 14:00 – 16:30 PARALLEL SESSION 3 / PART 2 Hall N9/10 GORD: Challenges and opportunities Director: Jean Paul Galmiche, France Chairs: J. Tack, Belgium; P. Sharma, USA 14:00 – 14:30 New endoscopic imaging modalities: What do they add? Prateek Sharma, USA 14:30 – 15:00 Extra-oesophageal manifestations of GORD: Are they really linked, and can they be treated? Daniel Sifrim, Belgium 15:00 – 15:30 Medical treatment: Optimising the old and introducing the new Jan Tack, Belgium 15:30 – 16:00 Endoscopic treatment of GORD: A critical reappraisal Guido Costamagna, Italy 16:00 – 16:30 The role of surgery in the long-term treatment of GORD Lars Lundell, Sweden 11:00 – 13:00 PARALLEL SESSION 4/ PART 1 Hall N11/12 Surgery: New techniques in colorectal surgery Directors: Alexander Engel, The Netherlands; Jan van Lanschot, The Netherlands Chairs: Antonio Lacy, Spain; Ronan O’Connell, Ireland 11:00 – 11:30 TEMS versus EMR: Too much or not enough? Evelien Dekker, The Netherlands 11:30 – 12:00 NOTES: Is anyone taking note? Thomas Roesch, Germany 12:00 – 12:30 Robotics: Only for whiz kids? David Jayne, UK 9
Page 1 and 2: Welcome address II about GasTRo 200
Page 3 and 4: Anthony T. R. Axon President, OMED
Page 5 and 6: InVITaTIon GASTRO 2009 UEGW/WCOG, L
Page 7 and 8: Professor Guido Tytgat, The Netherl
Page 9 and 10: ABOUT UEGF - THE VOICE OF EUROPEAN
Page 11 and 12: In creating the WGO Training Center
Page 13 and 14: oMeD - WoRlD oRGanIsaTIon of DIGesT
Page 15 and 16: GeneRal sPonsoRs a Actial Pharmaceu
Page 17 and 18: CONGRESS INFORMATION
Page 19 and 20: ReGIsTRaTIon Desk Opening Hours Fri
Page 21 and 22: The Press Centre is managed by the
Page 23 and 24: 6 conGRess InfoRMaTIon Watford 9 8
Page 25 and 26: - Promoting Global Digestive Health
Page 27 and 28: oPenInG PlenaRY sessIon The Plenary
Page 29 and 30: GI nURses 2009 - esGena/sIGnea conf
Page 31 and 32: SCIENTIFIC PROGRAMME
Page 33 and 34: Time Halls 09:00 - 10:30 11:00 - 16
Page 35 and 36: oVeRVIeW - MonDaY, noVeMbeR 23, 200
Page 37 and 38: oVeRVIeW - TUesDaY, noVeMbeR 24, 20
Page 39 and 40: oVeRVIeW - WeDnesDaY, noVeMbeR 25,
Page 41 and 42: GASTRO 2009 YOUNG CLINICIANS PROGRA
Page 43 and 44: YcP coRe-WoRksHoP PRoGRaMMe THe bUl
Page 45 and 46: POSTGRADUATE TEACHING PROGRAMME
Page 47: 11:20 - 11:40 Detection of early up
Page 51 and 52: sUnDaY, noVeMbeR 22, 2009 08:30 - 0
Page 53 and 54: PosTGRaDUaTe TeacHInG PRoGRaMMe 11:
Page 55 and 56: PROGRAMME PER DAY
Page 57 and 58: 11:07 - 11:13 OP007 ENDOSCOPIC SUBM
Page 59 and 60: 11:00 - 11:10 OP017 INFLUENCE OF PA
Page 61 and 62: 12:00 - 12:10 OP032 OBJECTIVE PREDI
Page 63 and 64: 14:20 - 14:30 OP049 EFFECTS OF BONE
Page 65 and 66: 15:10 - 15:20 OP062 WEIGHT GAIN AFT
Page 67 and 68: 15:00 - 15:10 OP079 FIRSTDEGREE R
Page 69 and 70: 14:20 - 14:30 OP096 IBS SUBTYPING B
Page 71 and 72: fRee PaPeR sessIon 15:45 - 17:15 N7
Page 73 and 74: sYMPosIUM 15:45 - 17:15 Platinum 3/
Page 75 and 76: 17:05 - 17:15 OP139 EROSIVE AND NON
Page 77 and 78: sYMPosIUM 08:30 - 10:30 S8/9 noTes:
Page 79 and 80: 08:40 - 08:50 OP163 DETECTION OF L
Page 81 and 82: 08:50 - 09:00 OP176 CAN WE SHORTEN
Page 83 and 84: 10:10 - 10:20 OP196 A RANDOMIZED CO
Page 85 and 86: fRee PaPeR sessIon 11:00 - 12:30 S8
Page 87 and 88: sYMPosIUM 11:00 - 12:30 N9/10 Do we
Page 89 and 90: 12:00 - 12:10 OP243 PREDICTION OF S
Page 91 and 92: 14:00 - 14:20 Molecular tools for e
Page 93 and 94: 14:40 - 14:50 OP261 DEVELOPMENT OF
Page 95 and 96: 16:25 - 16:45 Upper GI perforations
Page 97 and 98: 16:05 - 16:25 Community dyspepsia m
Page 99 and 100:
16:35 - 16:45 OP301 COMPARISON BETW
Page 101 and 102:
16:35 - 16:45 OP319 THE OMEGA3 PO
Page 103 and 104:
08:50 - 09:00 OP325 DISEASE ACTIVIT
Page 105 and 106:
08:30 - 08:50 How to treat: Best ev
Page 107 and 108:
10:00 - 10:10 OP350 HISTOPATHOLOGIC
Page 109 and 110:
09:40 - 09:50 OP372 A POSSIBLE TROP
Page 111 and 112:
12:20 - 12:30 OP393 MAJOR REDUCTION
Page 113 and 114:
11:40 - 12:00 Advances in treatment
Page 115 and 116:
11:30 - 11:40 OP420 THERAPEUTIC EFF
Page 117 and 118:
15:00 - 15:10 OP441 COMPARISON OF A
Page 119 and 120:
14:50 - 15:00 OP458 EFFECT OF BASEL
Page 121 and 122:
14:40 - 14:50 OP468 SENTINEL NODE P
Page 123 and 124:
Neurogastroenterology & Motility Al
Page 125 and 126:
LUNCH SESSIONS PER DAY
Page 127 and 128:
Room sG5 Preventing and managing si
Page 129 and 130:
POSTER SESSIONS PER DAY
Page 131 and 132:
P0012 EFFICACY OF THROMBINFIBRIN
Page 133 and 134:
P0033 USEFULLNESS OF NONINVASIVE
Page 135 and 136:
P0055 SIGNIFICANCE OF FUNGAL TRANS
Page 137 and 138:
P0079 CHANGES IN THE ExPRESSION OF
Page 139 and 140:
P0101 ExPRESSION OF THROMBOSPONDIN
Page 141 and 142:
P0121 VALIDITY OF ENDOSCOPIC SUBMUC
Page 143 and 144:
P0144 USEFULNESS OF ELECTROGASTROGR
Page 145 and 146:
P0168 COMPARISON BETWEEN ESD AND CO
Page 147 and 148:
P0189 HIGH RESOLUTION COMPUTED TOMO
Page 149 and 150:
P0211 SCREENING COLONOSCOPY IN FIRS
Page 151 and 152:
P0234 EMMPRIN, MATRIx METALLOPROTEI
Page 153 and 154:
P0258 SUCCESSFUL AMPLIFICATION OF C
Page 155 and 156:
P0279 COLONIC MUCOSAL CYTOkINE ExPR
Page 157 and 158:
P0301 FAMILIAL AND SPORADIC INFLAMM
Page 159 and 160:
P0320 PERIANAL DISEASE, SMALL BOWEL
Page 161 and 162:
P0343 ELAEAGNUS ANGUSTIFOLIA FRUIT
Page 163 and 164:
P0364 EFFECTS OF ANTIINFLAMMATORY
Page 165 and 166:
P0387 SUSTAINED EFFICACY OF ORAL PR
Page 167 and 168:
P0410 DEVELOPMENT OF CELLASSOCIAT
Page 169 and 170:
P0434 SECONDARY APPENDICEAL TUMOURS
Page 171 and 172:
P0458 EM2+ ELISA: A SEROLOGICAL TES
Page 173 and 174:
P0479 SERUM HEPCIDIN LEVELS IN ALCO
Page 175 and 176:
P0503 ENDOTOxIN BUT NOT BACTERIAL D
Page 177 and 178:
P0524 DISCRIMINATIVE ROLE OF THE NE
Page 179 and 180:
P0545 THE USEFULNESS OF NARROW BAND
Page 181 and 182:
P0567 UNSEDATED TRANSNASAL OESOPHA
Page 183 and 184:
P0590 QUALITY CONTROL OF COLONOSCOP
Page 185 and 186:
P0616 FAILED CANNULATION AFTER INIT
Page 187 and 188:
P0638 SPIRAL ENTEROSCOPY ERCP IN SU
Page 189 and 190:
P0662 ENDOSCOPIC FEATURES OF SMALL
Page 191 and 192:
P0684 THE VALUE OF REALTIME CONTR
Page 193 and 194:
P0707 A NOVEL SURGICAL TECHNIQUE US
Page 195 and 196:
P0730 OVERALL SUCCESS RATES IN THE
Page 197 and 198:
P0741 PREDICTION OF THE NEED FOR EN
Page 199 and 200:
P0763 THE HISTOLOGICAL DYNAMICS AND
Page 201 and 202:
PosTeR sessIon Intestinal disorders
Page 203 and 204:
P0807 HLA GENE DOSE EFFECT AND HELI
Page 205 and 206:
P0828 LTNS001, A NAPROxEN PRODR
Page 207 and 208:
P0852 COMPREHENSIVE EVALUATION OF I
Page 209 and 210:
P0877 E3710, A NEW PROTON PUMP INHI
Page 211 and 212:
P0900 OESOPHAGEAL CANCER PROFILE IN
Page 213 and 214:
P0921 GASTRIC EMPTYING MEASUREMENTS
Page 215 and 216:
P0942 UNDETECTED COLORECTAL CANCER
Page 217 and 218:
P0965 ASCITES ON CT SCAN IS A FACTO
Page 219 and 220:
P0987 THE SIGNIFICANCE OF MONITORIN
Page 221 and 222:
P1009 kINOME PROFILING OF INFLAMED
Page 223 and 224:
P1030 URINARY METABOLIC PROFILING S
Page 225 and 226:
P1051 THE PROFILE OF INFLAMMATORY B
Page 227 and 228:
P1071 EVIDENCE QUALITY ASSESSMENT F
Page 229 and 230:
P1092 A COMBINED DELAYED AND ExTEND
Page 231 and 232:
P1114 REDUCED MUCOSAL EOSINOPHIL AC
Page 233 and 234:
P1136 ANTICANCER EFFECTS OF ASTAxAN
Page 235 and 236:
P1159 DETECTION OF ADVANCED NEOPLAS
Page 237 and 238:
P1180 HISTOLOGICAL STEATOSIS PRESEN
Page 239 and 240:
P1203 TRANSFORMING GROWTH FACTOR BE
Page 241 and 242:
P1227 VALIDATION OF NAFLD FIBROSIS
Page 243 and 244:
P1251 PREDICTORS RELATED TO SURVIVA
Page 245 and 246:
P1275 MAGNIFYING ENDOSCOPIC FINDING
Page 247 and 248:
P1299 USEFULNESS OF MEASURING WIDTH
Page 249 and 250:
P1323 INCIDENCE OF BACTEREMIA AFTER
Page 251 and 252:
P1344 ERCP IN PATIENTS WITH BILLROT
Page 253 and 254:
P1366 THE PILLCAM© COLON CAPSULE F
Page 255 and 256:
P1389 IMAGING OF AN Ex VIVO PANCREA
Page 257 and 258:
P1413 LEPTIN AND ADIPONECTIN PLASMA
Page 259 and 260:
P1438 ENDOSCOPIC VISIBLE LIGHT SPEC
Page 261 and 262:
P1458 EFFICIENCY OF COMBINED ENDOSC
Page 263 and 264:
P1470 ASSOCIATION BETWEEN NONSTEROI
Page 265 and 266:
P1491 CORRELATION OF PEPSINOGEN I,
Page 267 and 268:
PosTeR sessIon Intestinal disorders
Page 269 and 270:
P1536 ARE HOSPITAL DOCTORS FORGETTI
Page 271 and 272:
P1557 ESOPHAGEAL BIOPSIES IN PATIEN
Page 273 and 274:
P1580 HISTOLOGICAL STUDY OF THE GAS
Page 275 and 276:
P1605 INCIDENCE OF GASTROESOPHAGEAL
Page 277 and 278:
P1628 PATTERNS OF LARYNGOPHARYNGEAL
Page 279 and 280:
PosTeR sessIon Paediatric gastroent
Page 281 and 282:
P1675 NEOANGIOGENESIS GOING WITH HE
Page 283 and 284:
P1699 THE UTILITY OF CONDITIONING S
Page 285 and 286:
P1722 PERIPHERAL TLYMPHOCYTES FRO
Page 287 and 288:
P1743 THE IMMUNODULATORY PROPERTIES
Page 289 and 290:
P1762 THE INCIDENCE OF COLORECTAL C
Page 291 and 292:
P1786 ENDOLUMINAL IMAGING OF COLITI
Page 293 and 294:
P1810 PROTECT1 STUDY OF INTESTINE
Page 295 and 296:
PosTeR sessIon nerve, gut and motil
Page 297 and 298:
P1852 LUBIPROSTONE INITIATES IMPROV
Page 299 and 300:
P1869 NEk2 AS A NOVEL MOLECULAR TAR
Page 301 and 302:
P1890 HIGH BMI, NON USE OF ASPIRIN
Page 303 and 304:
P1911 CURCUMIN PREVENTS LIVER FIBRO
Page 305 and 306:
P1932 DEGREE OF THROMBOCYTOPENIA AS
Page 307 and 308:
P1954 MUTATIONS IN PkR EIF2 ALPHA
Page 309 and 310:
P1975 ExTENDED TREATMENT DURATION O
Page 311 and 312:
P1995 EPIDEMIOLOGY AND RISk FACTORS
Page 313 and 314:
P2017 SEDATION DURING UPPER ENDOSCO
Page 315 and 316:
P2037 BASAL PROTRUSION OF ULCERS IN
Page 317 and 318:
P2059 RETROSPECTIVE AUDIT OF HEALTH
Page 319 and 320:
P2081 ENDOSCOPIC RETROGRADE CHOLAN
Page 321 and 322:
P2102 EUSFNA PREDICTS 5YEAR SUR
Page 323 and 324:
P2124 ANTISECRETORY FACTOR (AF) AFF
Page 325 and 326:
P2146 GLUCOSE TOLERANCE, INSULIN SE
Page 327 and 328:
P2167 RANDOMIZED CONTROLLED TRIAL C
Page 329 and 330:
GasTRo 2009 UeGW WcoG, london would
Page 331 and 332:
WORKING PARTY REPORTS
Page 333 and 334:
Wednesday, November 25, 2009 08:30
Page 335 and 336:
ESGE/OMED LEARNING AREA and ULTRASO
Page 337 and 338:
esGe/oMeD lecTURe THeaTRe Experts i
Page 339 and 340:
GasTRo 2009 PosTGRaDUaTe coURse: cl
Page 341 and 342:
COMMON INTEREST GROUP MEETINGS
Page 343 and 344:
15:40 - 16:30 Session 5: EU Guideli
Page 345 and 346:
13:50 - 14:10 Indian North-South sh
Page 347 and 348:
IBD infusion unit performance. The
Page 349 and 350:
EDMC: 5th workshop on severe GI Mot
Page 351 and 352:
BUSINESS MEETINGS and PRESS CONFERE
Page 353 and 354:
EAGE Saturday, November 21, 2009 14
Page 355 and 356:
SATELLITE SYMPOSIA and BREAKFAST ME
Page 357 and 358:
19:05 - 19:20 Double Ballon Endosco
Page 359:
Tuesday, November 24, 2009 18:00 -
Page 362 and 363:
GI nURses 2009 esGena/sIGnea lonDon
Page 364 and 365:
GI nURses 2009 PRoGRaMMe saTURDaY,
Page 366 and 367:
GI nURses 2009 - PRoGRaMMe oVeRVIeW
Page 368 and 369:
GI nURses 2009 - DeTaIleD PRoGRaMMe
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 381 and 382:
FUN RUN, PUBLIC HEALTH DAY and SUPP
Page 383 and 384:
RUnnInG TRack 343
Page 385 and 386:
Half- anD fUll-DaY ToURs Take advan
Page 387 and 388:
favourite Royal Residence of Queen
Page 389 and 390:
Tuesday, November 24, 2009 08:30 -
Page 391 and 392:
There are many coaching inns, inclu
Page 393 and 394:
Day 3 - Full day at leisure. you wi
Page 395 and 396:
and is home to the nationally known
Page 397 and 398:
LIST OF REVIEWERS
Page 399 and 400:
a Aabakken, Lars Abraldes, Juan G A
Page 401 and 402:
k Karagiannis, John A Kaser, Arthur
Page 403 and 404:
T Tack, Jan Tamori, Akihiro Tannapf
Page 405 and 406:
INDEX OF AUTHORS (CORE PROGRAMME)
Page 407 and 408:
a A, J.: P1590 Aabakken, L.: OP209
Page 409 and 410:
Alexander, S.M.: P1892 Alexandrakis
Page 411 and 412:
Arfini, C.: P0482 Argent, B.E.: OP4
Page 413 and 414:
Banaee, F.: P1244 Banai, J.: P0317,
Page 415 and 416:
Benizri, E.: P1420 Benjamin, J.: P1
Page 417 and 418:
Bojarski, C.: P0166 Bojic, D.: P178
Page 419 and 420:
Bromley, J.: OP213 Bronowicki, J.P.
Page 421 and 422:
Candel, F.J.: P2024 Candel Erenas,
Page 423 and 424:
Chan, K.W.: OP350 Chan, S.: OP073 C
Page 425 and 426:
Chun, H.J.: OP175, OP180*, OP376*,
Page 427 and 428:
Cosnes, J.: P1052, P1816 Coss-Adame
Page 429 and 430:
David, G.: P0317, P0318, P0320 Davi
Page 431 and 432:
DeOliveira, T.: P1412* Depoortere,
Page 433 and 434:
Doulgeroglou, V.G.: P0759 Douma, K.
Page 435 and 436:
Engel, H.: P0801 Engelen, S.M.E.: O
Page 437 and 438:
Ferrante, M.: P0328, P0351, P1044 F
Page 439 and 440:
Froehlich, F.: P0308, P1087, P1091,
Page 441 and 442:
Gebel, M.J.: OP354, P0486, P1259 Ge
Page 443 and 444:
Gordillo, J.: P1082, P1083, P1751,
Page 445 and 446:
Habbema, D.J.D.: P0427 Haber, G.: 5
Page 447 and 448:
Healy, L.A.: P0088, P0153, P1676 He
Page 449 and 450:
Horak, J.: OP193* Horev, N.: P0039
Page 451 and 452:
Illueca, M.: P0926, P0928, P0929 Il
Page 453 and 454:
Jelev, D.T.: P0514 Jelsness-Jørgen
Page 455 and 456:
Kalantzis, N.: P0175, P0896, P0977*
Page 457 and 458:
Kelly, C.: P1666 Kelly, D.: P0201 K
Page 459 and 460:
Kindt, S.: OP273*, P0133, P1838 Kin
Page 461 and 462:
Koutsoumpas, A.L.: P0759, P1179 Kov
Page 463 and 464:
Laheij, R.J.: P0961 Laheij, R.J.F.:
Page 465 and 466:
Lee, S.: OP291, OP470*, P0237, P040
Page 467 and 468:
Lindblad, M.: P2120 Lindegren, H.:
Page 469 and 470:
M Ma, C.: P1758 Ma, S.: P0458 Ma, X
Page 471 and 472:
Marcelis, Q.: OP056 Marchese, A.: P
Page 473 and 474:
Mayberry, J.: P1792 Mayberry, J.F.:
Page 475 and 476:
Milla, P.: OP261 Milla, P.J.: OP182
Page 477 and 478:
Moreira, M.J.: P1023*, P2105 Moreir
Page 479 and 480:
Nagtegaal, I.D.: P1142, P1146* Nagy
Page 481 and 482:
Ninomiya, S.: P0547 Nio, C.: OP250*
Page 483 and 484:
Okamoto, N.: P1459 Okamoto, R.: OP0
Page 485 and 486:
Pahuja, S.: P0521 Paik, C.: P2181 P
Page 487 and 488:
Pazurek, M.: P0233 Pearce, C.: P207
Page 489 and 490:
Pironi, L.: 56 Pirozzi, C.: P0297 P
Page 491 and 492:
Pucci, M.: P0067 Puente, J.J.: P115
Page 493 and 494:
Reinisch, W.: OP151, OP323, P0315,
Page 495 and 496:
Rossi, M.: OP379, P2187 Rosso, L.:
Page 497 and 498:
Salimullah, A.: P0242 Salines, E.:
Page 499 and 500:
Schäfer, K.: OP085* Schäfer, M.:
Page 501 and 502:
Shaposhnikova, N.A.: P0492, P1919 S
Page 503 and 504:
Širca-Čampa, A.: P1540 Siriwardan
Page 505 and 506:
Spieker, T.: OP308* Spiers, H.: OP1
Page 507 and 508:
Sutton, R.: OP281 Suzuki, D.: P0676
Page 509 and 510:
Tappenden, K.A.: OP141, P0814 Tardi
Page 511 and 512:
Tondi, P.: P1797 Tondu, F.: P1548 T
Page 513 and 514:
Uchiyama, Y.: OP042 Udani, B.: P101
Page 515 and 516:
Van Lommel, L.: P1031* Van Loo, D.:
Page 517 and 518:
Visokai, V.: P0706 Visschers, R.G.J
Page 519 and 520:
Wernersson, B.: P0926 Wesdorp, E.I.
Page 521 and 522:
Yamagami, H.: P0663 Yamagata, T.: P
Page 523 and 524:
Zagainov, V.: P1993 Zagainova, E.:
Page 525 and 526:
LIST OF EXHIBITORS
Page 527 and 528:
are seiten kument)
Page 529 and 530:
PLANS OF EXCEL LONDON
Page 531 and 532:
flooR Plan scIenTIfIc coRe PRoGRaMM
Page 533 and 534:
flooR Plan GI nURses 2009 esGena/sI
Page 535 and 536:
flooR Plan PUblIc HealTH DaY 495
show all

Table of conTenTs Welcome address II about GasTRo 2009, UeGW ...

Create successful ePaper yourself

Delete template?

Save as template?